792 results
Search Results
2. How free are Canada's unmuzzled scientists?
- Author
-
Vogel, Lauren
- Subjects
SCIENTIFIC communication ,SCIENTISTS ,MANUSCRIPTS ,CONFERENCE papers ,MEDICAL policy laws ,LIBERTY ,SCIENCE ,LABORATORY personnel - Abstract
The article discusses the sanctions of scientists to speak freely abut their works by the Liberal government of Canada. It notes the 2013 survey of trade union Professional Institute of the Public Service of Canada (PIPSC) which reported the highest rates of interference by management with manuscripts and conference presentations among members of government department Health Canada. It also notes the call of PIPSC and Evidence for Democracy for a legacy of draconian communication policies.
- Published
- 2016
- Full Text
- View/download PDF
3. Slow-burning smokes become a hot item.
- Author
-
Sibbald, Barbara
- Subjects
CIGARETTES ,CIGARETTE industry ,TOBACCO industry ,SMOKING & fires ,CIGARETTE paper - Abstract
Presents information on the planned introduction of reduced ignition propensity (RIP) cigarettes in Canada by 2005. Market reach of Merit, the first RIP cigarette in the world manufactured by Philip Morris; Statistics on fires caused by careless smoking in Canada, as of 2003; Objection regarding the level of toxicity of RIP cigarettes.
- Published
- 2003
4. CMA proposes options for private-public split.
- Author
-
Kondro, Wayne and Sibbald, Barbara
- Subjects
MEDICAL care ,ANNUAL meetings - Abstract
This article reports on the discussion paper, It's About Access! Informing the Debate on Public and Private Health Care, which was released by the Canadian Medical Association (CMA). Attendees at the CMA Annual Meeting will be asked to use the discussion paper to address the split between the private and public health care. The possible scenarios for the changes in the Canadian health care system are highlighted. The paper was co-authored by Dr. Robert Hollinshead.
- Published
- 2006
- Full Text
- View/download PDF
5. Almost famous: E. Clark Noble, the common thread in the discovery of insulin and vinblastine.
- Author
-
Wright Jr, James R. and Wright, James R Jr
- Subjects
INSULIN research ,CANCER chemotherapy ,CANCER treatment ,VINCAMINE ,INSULIN ,VINBLASTINE ,HISTORY - Abstract
Clark Noble was one of the first members of the University of Toronto insulin team and came within a coin toss of replacing Charles Best as Frederick Banting's assistant during the summer of 1921. Noble performed important early studies helping to characterize insulin's action, and he co-authored many of the original papers describing insulin. Because mass production of insulin from livestock pancreata had proved elusive throughout 1922, J.J.R. Macleod hired Noble during the summer of 1923 to help him test and develop a new method for producing commercial quantities of insulin that Macleod believed would revolutionize insulin production. However, commercial production of insulin from fish proved impractical and was dropped by 1924, as methods to produce large quantities of mammalian insulin had improved very rapidly. Noble later played a small but critical role in the most important Canadian contribution to cancer chemotherapy research: the discovery of vinca alkaloids by his brother Robert Laing Noble. Although one might expect that a physician involved in 2 of Canada's most important medical discoveries during the 20th century must be famous, such was not Clark Noble's fate. He died without so much as an obituary in CMAJ. INSET: From our files. [ABSTRACT FROM AUTHOR]
- Published
- 2002
6. The Canadian Partnership for Tomorrow Project: a pan-Canadian platform for research on chronic disease prevention.
- Author
-
Dummer, Trevor J.B., Awadalla, Philip, Boileau, Catherine, Craig, Camille, Fortier, Isabel, Goel, Vivek, Hicks, Jason M.T., Jacquemont, Sébastien, Knoppers, Bartha Maria, Le, Nhu, McDonald, Treena, McLaughlin, John, Mes-Masson, Anne-Marie, Nuyt, Anne-Monique, Palmer, Lyle J., Parker, Louise, Purdue, Mark, Robson, Paula J., Spinelli, John J., and Thompson, David
- Subjects
PREVENTION of chronic diseases ,HEALTH policy ,PREVENTIVE medicine ,COHORT analysis ,POPULATION health management ,PUBLIC health - Abstract
Background: Understanding the complex interaction of risk factors that increase the likelihood of developing common diseases is challenging. The Canadian Partnership for Tomorrow Project (CPTP) is a prospective cohort study created as a population-health research platform for assessing the effect of genetics, behaviour, family health history and environment (among other factors) on chronic diseases.Methods: Volunteer participants were recruited from the general Canadian population for a confederation of 5 regional cohorts. Participants were enrolled in the study and core information obtained using 2 approaches: attendance at a study assessment centre for all study measures (questionnaire, venous blood sample and physical measurements) or completion of the core questionnaire (online or paper), with later collection of other study measures where possible. Physical measurements included height, weight, percentage body fat and blood pressure. Participants consented to passive follow-up through linkage with administrative health databases and active follow-up through recontact. All participant data across the 5 regional cohorts were harmonized.Results: A total of 307 017 participants aged 30-74 from 8 provinces were recruited. More than half provided a venous blood sample and/or other biological sample, and 33% completed physical measurements. A total of 709 harmonized variables were created; almost 25% are available for all participants and 60% for at least 220 000 participants.Interpretation: Primary recruitment for the CPTP is complete, and data and biosamples are available to Canadian and international researchers through a data-access process. The CPTP will support research into how modifiable risk factors, genetics and the environment interact to affect the development of cancer and other chronic diseases, ultimately contributing evidence to reduce the global burden of chronic disease. [ABSTRACT FROM AUTHOR]- Published
- 2018
- Full Text
- View/download PDF
7. Characteristics of primary care practices by proportion of patients unvaccinated against SARS-CoV-2: a cross-sectional cohort study.
- Author
-
Shuldiner, Jennifer, Green, Michael E., Kiran, Tara, Khan, Shahriar, Frymire, Eliot, Moineddin, Rahim, Kerr, Meghan, Tadrous, Mina, Nowak, Dominik Alex, Kwong, Jeffrey C., Hu, Jia, Witteman, Holly O., Hamilton, Bryn, Bogoch, Isaac, Marshall, Lydia-Joy, Ikura, Sophia, Bar-Ziv, Stacey, Kaplan, David, and Ivers, Noah
- Subjects
PRIMARY care ,VACCINATION status ,VACCINATION ,VACCINATION coverage ,COVID-19 pandemic ,PATIENT-centered medical homes ,VACCINE refusal - Abstract
Background: Variations in primary care practices may explain some differences in health outcomes during the COVID-19 pandemic. We sought to evaluate the characteristics of primary care practices by the proportion of patients unvaccinated against SARS-CoV-2. Methods: We conducted a population-based, cross-sectional cohort study using linked administrative data sets in Ontario, Canada. We calculated the percentage of patients unvaccinated against SARS-CoV-2 enrolled with each comprehensive-care family physician, ranked physicians according to the proportion of patients unvaccinated, and identified physicians in the top 10% (v. the other 90%). We compared characteristics of family physicians and their patients in these 2 groups using standardized differences. Results: We analyzed 9060 family physicians with 10 837 909 enrolled patients. Family physicians with the largest proportion (top 10%) of unvaccinated patients (n = 906) were more likely to be male, to have trained outside of Canada, to be older, and to work in an enhanced fee-for-service model than those in the remaining 90%. Vaccine coverage (≥ 2 doses of SARS-CoV-2 vaccine) was 74% among patients of physicians with the largest proportion of unvaccinated patients, compared with 87% in the remaining patient population. Patients in the top 10% group tended to be younger and live in areas with higher levels of ethnic diversity and immigration and lower incomes. Interpretation: Primary care practices with the largest proportion of patients unvaccinated against SARS-CoV-2 served marginalized communities and were less likely to use team-based care models. These findings can guide resource planning and help tailor interventions to integrate public health priorities within primary care practices. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
8. Health Canada needs to act on laboratory-developed diagnostics.
- Author
-
Holloway, Kelly, Miller, Fiona A., Rousseau, François, Gutierrez, Alberto, and Hogarth, Stuart
- Subjects
MEDICAL personnel ,HEALTH facilities ,MEDICAL device approval ,MEDICAL equipment laws ,MEDICAL laws ,HEALTH policy ,MOLECULAR diagnosis ,NEW product development laws - Abstract
Recent expansion of the molecular diagnostics industry has revealed weaknesses in Canada's regulatory system for laboratory-developed tests, which are not subject to statutory regulations on medical devices. Absent regulation as medical devices, the only controls on test performance are laboratory regulation and accreditation, which are heterogeneous and sometimes flawed and do not necessarily include assessment of test validity, safety and efficacy. Diagnostics developed as "test kits" and sold to laboratories, hospitals and clinics are considered to be in vitro diagnostics devices under Medical Devices Regulation in accordance with the federal I Food and Drugs Act i . [Extracted from the article]
- Published
- 2019
- Full Text
- View/download PDF
9. Canada's high drug prices under review.
- Author
-
Moulton, donalee
- Subjects
DRUG prices ,PHARMACEUTICAL policy ,DRUG laws ,REVIEW committees ,PHARMACEUTICAL services ,INDUSTRIES ,MEDICAL care costs ,HEALTH policy ,USER charges ,COST analysis - Abstract
The article reports on a discussion paper released by the Patented Medicine Prices Review Board which asks Canadians, physicians, and pharmaceutical companies to review the drug-pricing system in Canada, with the aim of modernizing and simplifying the regulatory framework on patented drug pricing. It highlights statistics which compare the cost of medicines in the country with others. The discussion paper is said to be a part of a consultation process designed to focus drug-pricing problems.
- Published
- 2016
- Full Text
- View/download PDF
10. False images top form of scientific misconduct.
- Author
-
Shuchman, Miriam
- Subjects
MALPRACTICE ,IMAGE processing ,MEDICAL laboratories ,MEDICAL research ,SCIENTISTS ,ORGANIZATIONAL behavior ,PHOTOGRAPHY -- Moral & ethical aspects ,DIGITAL image processing ,FRAUD in science ,NEWSLETTERS ,PUBLISHING ,RESEARCH ethics ,ETHICS - Abstract
The article discusses image manipulation, a medical laboratory misconduct wherein scientists publish microspic images that do not match the original data. Researchers who manipulate images may face significant consequences which include ending of research career. The number of image manipulation issues has reportedly increased, however there are no definite data as it can be hard to prove that the changes were intentional.
- Published
- 2016
- Full Text
- View/download PDF
11. Estimated mortality risk and use of palliative care services among home care clients during the last 6 months of life: a retrospective cohort study.
- Author
-
Murmann, Maya, Manuel, Douglas G., Tanuseputro, Peter, Bennett, Carol, Pugliese, Michael, Li, Wenshan, Roberts, Rhiannon, and Hsu, Amy T.
- Subjects
HOME care services ,PALLIATIVE treatment ,COHORT analysis ,MEDICAL care use ,ELDER care - Abstract
Background: In Canada, only 15% of patients requiring palliative care receive such services in the year before death. We describe health care utilization patterns among home care users in their last 6 months of life to inform care planning for older people with varying mortality risks and evolving care needs as they decline. Methods: Using population health administrative data from Ontario, we performed a retrospective cohort study involving home care clients aged 50 years and older who received at least 1 interRAI (Resident Assessment Instrument) Home Care assessment between April 2018 and September 2019. We report the proportion of clients who used acute care, long-term care, and palliative home care services within 6 months of their assessment, stratified by their predicted 6-month mortality risk using a prognostic tool called the Risk Evaluation for Support: Predictions for Elder-life in their Communities Tool (RESPECT) and vital status. Results: The cohort included 247 377 adults, 11.9% of whom died within 6 months of an assessment. Among decedents, 50.6% of those with a RESPECT-estimated median survival of fewer than 3 months received at least 1 nonphysician palliative home care visit before death. This proportion declined to 38.7% and 29.5% among decedents with an estimated median survival between 3 and 6 months and between 6 and 12 months, respectively. Interpretation: Many older adults in Ontario do not receive any palliative home care before death. Prognostic tools such as RESPECT may improve recognition of reduced life expectancies and palliative care needs of individuals in their final years of life. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
12. Perspectives of Canadian health leaders on the relationship between medical assistance in dying and palliative and end-of-life care services: a qualitative study.
- Author
-
Shapiro, Gilla K., Tong, Eryn, Nissim, Rinat, Zimmermann, Camilla, Allin, Sara, Gibson, Jennifer L., Lau, Sharlane C.L., Li, Madeline, and Rodin, Gary
- Subjects
ASSISTED suicide ,TERMINAL care ,MEDICAL assistance ,PALLIATIVE treatment ,INFORMATION services ,QUALITATIVE research - Abstract
Background: Medical assistance in dying (MAiD) was legalized in Canada in 2016, but coordination of MAiD and palliative and end-of-life care (PEOLC) services remains underdeveloped. We sought to understand the perspectives of health leaders across Canada on the relationship between MAiD and PEOLC services and to identify opportunities for improved coordination. Methods: In this quantitative study, we purposively sampled health leaders across Canada with expertise in MAiD, PEOLC, or both. We conducted semi-structured interviews between April 2021 and January 2022. Interview transcripts were coded independently by 2 researchers and reconciled to identify key themes using content analysis. We applied the PATH framework for Integrated Health Services to guide data collection and analysis. Results: We conducted 36 interviews. Participants expressed diverse views about the optimal relationship between MAiD and PEOLC, and the desirability of integration, separation, or coordination of these services. We identified 11 themes to improve the relationship between the services across 4 PATH levels: client-centred services (e.g., educate public); health operations (e.g., cultivate compassionate and proactive leadership); health systems (e.g., conduct broad and inclusive consultation and planning); and intersectoral initiatives (e.g., provide standard practice guidelines across health care systems). Interpretation: Health leaders recognized that cooperation between MAiD and PEOLC services is required for appropriate referrals, care coordination, and patient care. They identified the need for public and provider education, standardized practice guidelines, relationship-building, and leadership. Our findings have implications for MAiD and PEOLC policy development and clinical practice in Canada and other jurisdictions. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
13. The prevalence of tuberculosis infection among foreign-born Canadians: a modelling study.
- Author
-
Jordan, Aria Ed, Nsengiyumva, Ntwali Placide, Houben, Rein M.G.J., Dodd, Peter J., Dale, Katie D., Trauer, James M., Denholm, Justin T., Johnston, James C., Khan, Faiz Ahmad, Campbell, Jonathon R., and Schwartzman, Kevin
- Subjects
TUBERCULOSIS ,COUNTRY of origin (Immigrants) ,INFECTION ,CANADIANS ,MEDICAL screening - Abstract
Background: The prevalence of tuberculosis infection is critical to the design of tuberculosis prevention strategies, yet is unknown in Canada. We estimated the prevalence of tuberculosis infection among Canadian residents born abroad. Methods: We estimated the prevalence of tuberculosis infection by age and year of migration to Canada for people from each of 168 countries by constructing country-specific and calendar year–specific trends for annual risk of infection using a previously developed model. We combined country-specific prevalence estimates with Canadian Census data from 2001, 2006, 2011, 2016 and 2021 to estimate the overall prevalence of tuberculosis infection among foreign-born Canadian residents. Results: The estimated overall prevalence of tuberculosis infection among foreign-born people in Canada was 25% (95% uncertainty interval [UI] 20%–35%) for census year 2001, 24% (95% UI 20%–33%) for 2006, 23% (95% UI 19%–30%) for 2011, 22% (95% UI 19%–28%) for 2016 and 22% (95% UI 19%–27%) for 2021. The prevalence increased with age at migration and incidence of tuberculosis in the country of origin. In 2021, the estimated prevalence of infection among foreign-born residents was lowest in Quebec (19%, 95% UI 16%–24%) and highest in Alberta (24%, 95% UI 21%–28%) and British Columbia (24%, 95% UI 20%–30%). Among all foreign-born Canadian residents with tuberculosis infection in 2021, we estimated that only 1 in 488 (95% UI 185–1039) had become infected within the 2 preceding years. Interpretation: About 1 in 4 foreign-born Canadian residents has tuberculosis infection, but very few were infected within the 2 preceding years (the highest risk period for progression to tuberculosis disease). These data may inform future tuberculosis infection screening policies. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
14. What paperless office?
- Author
-
Martin, Shelley
- Subjects
MEDICAL records ,SURVEYS ,PHYSICIANS - Abstract
Reports that data from the Canadian Medical Association's (CMA) 2002 Physician Resource Questionnaire indicate that only a small percentage of Canadian physicians use electronic media to store active patient records. Percentage which use a combination of paper and electronic media; Number of physicians who claim that improving how patient information is shared is an important or very important potential benefit of electronic health records.
- Published
- 2002
15. Prevalence and nature of manufacturer-sponsored patient support programs for prescription drugs in Canada: a cross-sectional study.
- Author
-
Grundy, Quinn, Quanbury, Ashton, Hart, Dana, Chaudhry, Shanzeh, Tavangar, Farideh, Lexchin, Joel, Gagnon, Marc-André, and Tadrous, Mina
- Subjects
PATIENT compliance ,ORPHAN drugs ,PATIENT experience ,CROSS-sectional method ,BIOLOGICALS - Abstract
Background: Globally, pharmaceutical companies offer patient support programs in tandem with their products, which aim to enhance medication adherence and patient experience through education, training, support and financial assistance. We sought to identify the proportion and characteristics of such patient support programs in Canada and to describe the nature of supports provided. Methods: We conducted a crosssectional study to identify and characterize all marketed prescription drugs available in Canada as of Aug. 23, 2022, using the Health Canada Drug Product and CompuScript databases. To describe the nature of supports provided, we conducted a content analysis of publicly available patient support program websites and Web-based documents. Using logistic regression, we identified characteristics of drugs associated with having a patient support program including brand-name or branded generic (generic medications with a proprietary name), orphan (medications for rare diseases) or biologic drug status; estimated total cost of prescriptions dispensed at retail pharmacies; and price per unit. Results: Of the 2556 prescription drugs marketed by 89 companies in the study period, 256 (10.0%) had a patient support program in Canada. Many of the 89 drug manufacturers (n = 55, 61.8%) offered at least 1 patient support program, frequently relying on third-party administrators for delivery. Brandname and branded generic medications, biologic agents and drugs with orphan status were more likely to have a patient support program than generic drugs. Compared with drugs priced $1.01–$10.00 per unit, drugs priced $10.01–$100.00 per unit were nearly 8 times more likely to have a patient support program (adjusted odds ratio 7.54, 95% confidence interval 4.07– 14.64). Most sampled patient support programs included reimbursement navigation (n = 231, 90.2%) and clinical case management (n = 223, 87.1%). Interpretation: About 1 in 10 drugs marketed in Canada has a manufacturersponsored patient support program, but these are concentrated around brand-name, branded generic, biologic and high-cost drugs, often for rare diseases. To understand the impact of patient support programs on health outcomes and sustainable access to cost-effective medicines, greater transparency and independent evaluation of patient support programs is necessary. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
16. Changes in emergency department use in British Columbia, Canada, during the first 3 years of the COVID-19 pandemic.
- Author
-
Yao, Jiayun, Irvine, Michael A., Klaver, Braeden, Zandy, Moe, Dheri, Aman K., Grafstein, Eric, and Smolina, Kate
- Subjects
COVID-19 pandemic ,HOSPITAL emergency services ,PUBLIC health surveillance - Abstract
Background: Previous studies have shown reductions in the volume of emergency department visits early in the COVID-19 pandemic, but few have evaluated the pandemic's impact over time or stratified analyses by reason for visits. We aimed to quantify such changes in British Columbia, Canada, cumulatively and during prominent nadirs, and by reason for visit, age and acuity. Methods: We included data from the National Ambulatory Care Reporting System for 30 emergency departments across BC from January 2016 to December 2022. We fitted generalized additive models, accounting for seasonal and annual trends, to the monthly number of visits to estimate changes throughout the pandemic, compared with the expected number of visits in the absence of the pandemic. We determined absolute and relative differences at various times during the study period, and cumulatively since the start of the pandemic until the overall volume of emergency department visits returned to expected levels. Results: Over the first 16 months of the pandemic, the volume of emergency department visits was reduced by about 322 300 visits, or 15% (95% confidence interval 12%–18%), compared with the expected volume. A sharp drop in pediatric visits accounted for nearly one-third of the reduction. The timing of the return to baseline volume of visits differed by subgroup. The largest and most sustained decreases were in respiratory-related emergency department visits, visits among children, visits among oldest adults and non-urgent visits. Later in the pandemic, we observed increased volumes of highest-urgency visits, visits among children and visits related to ear, nose and throat. Interpretation: We have extended evidence that the impact of the COVID-19 pandemic and associated mitigation strategies on emergency department visits in Canada was substantial. Both our findings and methods are relevant in public health surveillance and capacity planning for emergency departments in pandemic and nonpandemic times. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
17. Pharmacare researchers win Bruce Squires Award.
- Author
-
Collier, Roger
- Subjects
AWARDS ,HEALTH insurance ,RESEARCH personnel - Abstract
The article announce the Bruce Squires Award received by the pharmacare researchers Steve Morgan from Canadian Medical Association Journal (CMAJ).
- Published
- 2017
- Full Text
- View/download PDF
18. Patent-drug price board to review guidelines.
- Author
-
Sibbald, Barbara
- Subjects
PRICING ,DRUGS ,PATENTS ,REVIEW committees - Abstract
Reports a review conducted by the Patented Medicine Prices Review Board on its guidelines on patented drugs pricing in Canada. Percentage increase in the price of all patented drugs in 2004; Background on the board; Frameworks presented by a discussion paper released by the board on March 9, 2005.
- Published
- 2005
- Full Text
- View/download PDF
19. Family physicians urge creation of "medical homes" for every Canadian.
- Author
-
Kondro, Wayne
- Subjects
MEDICAL care ,PRIMARY care ,SERVICES for patients ,PHYSICIANS ,HEALTH care teams - Abstract
The article reports on the call of family physicians to develop medical homes in the U.S. It states that U.S. President Barack Obama has shown interest to fund a medical home to oversee the conditions of chronically ill patients in the country. It cites that joining the agenda is the College of Family Physicians of Canada (CFPC) that released a discussion paper and called on governments to establish a medical home. The move of CFPC is not only intended for ill patients but for every Canadian.
- Published
- 2009
- Full Text
- View/download PDF
20. Art is science made clear.
- Author
-
Sibbald, Barbara
- Subjects
PERIODICALS ,MEDICINE & art ,ARTISTIC anatomy ,VARIATION in language - Abstract
The article provides information on the journal "Revue d'art canadienne/ Canadian Art Review" (RACAR). It cites that the said journal provides scholarly papers about medical aesthetic and anatomy in the 19th century. The journal serves as the Universities Art Association of Canada's publication produced with language variation.
- Published
- 2009
- Full Text
- View/download PDF
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.